Skip to main content

Research News

Pharma Courses
  • 16 years old team of young researchers developed salt-powered mini fridge for vaccine transport and storage

    Team of Young researchers, still in Indian school, developed a portable, electricity-free refrigeration unit using a salt solution to keep vaccines and other temperature-sensitive materials cool. Team consisting of Dhruv Chaudhary, Mithran Ladhania, and Mridul Jain, is known for their work on Thermavault, a device designed to transport vaccines, medicines, and even transplant organs.

  • Integrative approach reveals promising candidates for AD risk factors or targets for treatments

    A study published in the American Journal of Human Genetics by researchers at Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital provides solutions to the pressing need to identify factors that influence Alzheimer’s disease (AD) risk or resistance while providing an avenue to explore potential biological markers and therapeutic targets.

  • Microorganisms employ a secret weapon during metabolism
    In the global carbon cycle microorganisms have evolved a variety of methods for fixing carbon. Researchers from Bremen and Taiwan have investigated the methods that are utilized at extremely hot, acidic and sulfur-rich hydrothermal vents in shallow waters off the island of Kueishantao, Taiwan.
  • Common genetic variants linked to drug-resistant epilepsy
    Antiseizure medication is usually prescribed for people with the condition. However, for one in three people with epilepsy around 20 million individuals worldwide, current antiseizure medications are ineffective. This means that people will continue to have seizures despite taking medication – a condition called ‘drug resistance.
  • Stevens Researchers Put Glycemic Response Modeling On a Data Diet
    In a paper in the Journal of Diabetes Science and Technology, researchers at Stevens Institute of Technology offer a new approach: a data-sparse model capable of accurately predicting individual glycemic responses with no need for blood draws, stool samples, or other unpleasant testing. The key to their approach? Keeping track of what people actually eat.
  • FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy
    Calibr-Skaggs Institute for Innovative Medicines, the drug discovery division of Scripps Research, announced today that the FDA has cleared their investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy in patients with autoimmune conditions. Patient recruitment for the phase 1 trial will begin soon.
  • Starch-based microplastics could cause health risks in mice, study finds
    Wear and tear on plastic products releases small to nearly invisible plastic particles, which could impact people’s health when consumed or inhaled. To make these particles biodegradable, researchers created plastics from plant starch instead of petroleum.
  • Treatment for mitochondrial diseases within reach
    Mitochondrial diseases caused by POLG mutations vary in severity. In young children, these diseases can quickly result in brain damage and life-threatening liver problems while others suffer muscle weakness, epilepsy, and organ failure later in childhood. POLG mutations recently received media attention when Prince Frederik of Nassau in Luxembourg died in March 2025 at just 22 years of age.
  • HKU State Key Laboratory and InnoHK CVVT Successfully Develop Nasal Spray H5N1 Avian Influenza Vaccine
    The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong and the InnoHK Centre for Virology, Vaccinology and Therapeutics have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine.
  • Students lead breakthrough study on diabetes drugs and dementia risk
    Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies - medications that lower blood sugar and reduce the risk of heart disease in people with diabetes - affect the risk of developing dementia.
Subscribe to Research News